Actively Recruiting
Study on Different Phototherapy Methods for Treating Newborn Jaundice Comparing Continuous and Cycled Light Treatments with Varying Light Intensities
Led by Regionshospital Nordjylland · Updated on 2025-11-20
116
Participants Needed
2
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Neonatal jaundice affects about 60% of full-term newborns in their first week and can cause serious brain damage if untreated. Researchers are studying different phototherapy light treatments in newborns with neonatal hyperbilirubinemia to find the best intensity and compare continuous versus intermittent phototherapy. This randomized clinical trial includes newborns born after 33 weeks gestation weighing over 1800 grams, aiming to improve treatment effectiveness and support parent-infant bonding. Participants will receive 12 hours of double phototherapy using an overhead light and a light blanket. They will be randomly assigned to one of four groups continuous phototherapy at intensities of 40, 55, or 70 B5Wcm2nm, or intermittent phototherapy cycling 1.5 hours on and 1.5 hours off at 70 B5Wcm2nm overhead light intensity. The light intensity is adjusted by changing the distance between the infant and the light. During the study, infants will be closely monitored with blood tests measuring serum bilirubin and other markers before and after treatment. Researchers will assess bilirubin reduction after 12 hours and watch for any rebound increases. Feeding type and parental experiences will also be recorded. Follow-up includes reviewing hospital records 14 days later and a survey about feeding four months after treatment. Total participation lasts at least 12 hours with extended monitoring for outcomes and safety.
CONDITIONS
Brief Title
Newborn Jaundice - An Investigation of Different Approaches to Light Therapy
Research Team
E
Emil L Oehrstroem, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here